⌘K

Login Start Free

Home/Filings/4/0001209191-18-053125

4//SEC Filing

Graney Thomas 4

Accession 0001209191-18-053125

CIK 0000875320other

View on SEC.gov Company Profile

Filed

Oct 1, 8:00 PM ET

Accepted

Oct 2, 4:24 PM ET

Size

4.7 KB

Accession

0001209191-18-053125

Insider Transaction Report

Form 4

Period: 2018-10-01

VERTEX PHARMACEUTICALS INC / MAVRTX

Chief Financial Officer

Transactions

Sale
Common Stock
2018-10-01$193.24/sh−1,076$207,926→ 12,430 total

Footnotes (1)

[F1]Transaction made pursuant to Mr. Graney's company-approved trading plan under Rule 10b5-1.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

VERTEX PHARMACEUTICALS INC / MA

CIK 0000875320

Entity typeother

Related Parties

1

filerCIK 0001618275

Filing Metadata

Form type: 4
Filed: Oct 1, 8:00 PM ET
Accepted: Oct 2, 4:24 PM ET
Size: 4.7 KB

View on SEC.gov